Brief: PLx Pharma Reports Q1 Loss Per Share Of $0.73
14/05/2021 12:43
May 14 (Reuters) - PLx Pharma Inc PLXP.O :
* REPORTS FIRST QUARTER 2021 RESULTS AND PROVIDES BUSINESS
UPDATE
* Q1 LOSS PER SHARE $0.73
* Q1 EARNINGS PER SHARE ESTIMATE $-0.21 -- REFINITIV IBES
DATA
* VAZALORE'S U.S. COMMERCIAL LAUNCH ON TRACK FOR Q3 2021
* AS OF MARCH 31, 2021, CO HAD CASH AND CASH EQUIVALENTS OF
$84.4
MILLION
Source text for Eikon: ID:nGNX21GV8
Further company coverage: PLXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PLx Pharma Winddown
See all newsAustralia's Pilbara Minerals jumps on Pilgangoora lithium resource upgrade
Brief: Plx Pharma Winddown Terminated Employment Of Natasha Giordano, President And CEO, And Rita O'connor, CFO
Brief: PLx Pharma Inc. Enters Into A Stalking Horse Asset Purchase Agreement To Sell Vazalore And Substantially All Of Its Assets
U.S. STOCKS ON THE MOVE-HeartCore, Freight Technologies, MongoDB
Brief: Plx Pharma Inc. Receives Nasdaq Delisting Notice